Tenaya Therapeutics (TNYA) Capital Expenditures (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Capital Expenditures of -$461000.0 for Q1 2026, down 11425.0% year-over-year from N/an in Q1 2025, and down 23150.0% quarter-over-quarter from $2000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Capital Expenditures (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$461000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 11425.0% year-over-year to -$461000.0; the TTM figure through Mar 2026 stood at -$1.0 million (down 54.12% YoY), while the FY2025 annual figure was -$571000.0, up 12.96% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$461000.0, down from $2000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $19.7 million in Q3 2022, with the low at -$19.0 million in Q4 2022.
- The 5-year median for Capital Expenditures is $7000.0 (2024), against an average of -$16000.0.
- The sharpest annual moves came in 2023 and 2026: Capital Expenditures soared 2616.0% in 2023, then slumped 11425.0% in 2026.
- Tenaya Therapeutics' Capital Expenditures stood at -$19.0 million in 2022, then jumped by 98.72% to -$244000.0 in 2023, then sank by 505.33% to -$1.5 million in 2024, then surged by 100.14% to $2000.0 in 2025, then tumbled by 23150.0% to -$461000.0 in 2026.
- Business Quant data shows TNYA's Capital Expenditures at -$461000.0 in Q1 2026, $2000.0 in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37,000.00 |
| Jun 30, 2026 | 37,000.00 |
| Mar 31, 2026 | -461,000.00 |
| Mar 31, 2026 | -461,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | -1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | 529,000.00 |
| Jun 30, 2025 | 529,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 630,000.00 |
| Jun 30, 2024 | 630,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |